Beranda › Kanker Kelenjar Liur › Massachusetts › Boston
Uji klinis Kanker Kelenjar Liur di Boston, MA
5 studi untuk Kanker Kelenjar Liur mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Menerima pesertaFase 2
- Boston Medical Center, Boston
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Menerima pesertaFase 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Menerima pesertaFase awal 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Menerima pesertaFase 1/2
- Dana Farber Cancer Institute, Boston
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Menerima pesertaFase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Uji klinis Kanker Kelenjar Liur di kota lain
- Nashville, TN5 studi
- Houston, TX5 studi
- New York City, NY4 studi
- Dallas, TX3 studi
- Philadelphia, PA3 studi
- Highlands Ranch, CO3 studi
Studi lain di Boston
- Kanker Payudara112 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)85 studi
- Kanker Metastatik63 studi
- Kanker Kolorektal63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.